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We thank Wang et al. for their interest in our study. Our study revealed that aristolochic acid I (AAI) can induce mouse liver cancers in a dose-dependent manner, and CCl4 , a liver injury agent, may enhance the AAI-induced tumorigenesis in adult mice. More importantly, AAI-DNA adduct was detected in 26% of Chinese hepatocellular carcinoma (HCC) patients, which is consistent with data from aristolochic acid (AA)-related mutational signature analysis.